S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:AHCO

AdaptHealth Stock Forecast, Price & News

$18.40
-1.00 (-5.15%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.36
$19.31
50-Day Range
$18.40
$25.51
52-Week Range
$18.24
$41.58
Volume
696,048 shs
Average Volume
715,661 shs
Market Capitalization
$2.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.15
30 days | 90 days | 365 days | Advanced Chart
Receive AHCO News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.


AdaptHealth logo

About AdaptHealth

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
4,700
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.06 billion
Cash Flow
$1.18 per share
Book Value
$4.40 per share

Profitability

Net Income
$-64.48 million
Pretax Margin
9.29%

Debt

Price-To-Earnings

Miscellaneous

Free Float
109,342,000
Market Cap
$2.43 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/04/2021
Today
1/23/2022
Next Earnings (Estimated)
3/03/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.88 out of 5 stars

Medical Sector

32nd out of 1,419 stocks

Home Health Care Services Industry

2nd out of 9 stocks

Analyst Opinion: 3.3Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 3.1 5 -4 -3 -2 -1 -












AdaptHealth (NASDAQ:AHCO) Frequently Asked Questions

Is AdaptHealth a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AdaptHealth stock.
View analyst ratings for AdaptHealth
or view top-rated stocks.

How has AdaptHealth's stock been impacted by Coronavirus (COVID-19)?

AdaptHealth's stock was trading at $15.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AHCO stock has increased by 16.3% and is now trading at $18.40.
View which stocks have been most impacted by COVID-19
.

When is AdaptHealth's next earnings date?

AdaptHealth is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for AdaptHealth
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.28 by $0.08. The business earned $653.30 million during the quarter, compared to analyst estimates of $638.74 million. AdaptHealth had a trailing twelve-month return on equity of 9.73% and a net margin of 4.86%. The firm's revenue for the quarter was up 129.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.05 earnings per share.
View AdaptHealth's earnings history
.

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth issued an update on its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.41 billion-$2.46 billion, compared to the consensus revenue estimate of $2.41 billion.

What price target have analysts set for AHCO?

5 brokers have issued 12 month price objectives for AdaptHealth's shares. Their forecasts range from $30.00 to $46.00. On average, they expect AdaptHealth's stock price to reach $37.40 in the next year. This suggests a possible upside of 103.3% from the stock's current price.
View analysts' price targets for AdaptHealth
or view top-rated stocks among Wall Street analysts.

Who are AdaptHealth's key executives?

AdaptHealth's management team includes the following people:

What other stocks do shareholders of AdaptHealth own?

What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.30%), Tributary Capital Management LLC (0.04%), West Coast Financial LLC (0.03%), Russell Investments Group Ltd. (0.01%) and Cutler Group LP (0.00%). Company insiders that own AdaptHealth stock include Alan G Quasha, Assured Investment Management, Dale B Wolf, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk and Stephen P Griggs.
View institutional ownership trends for AdaptHealth
.

Which institutional investors are selling AdaptHealth stock?

AHCO stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc.. Company insiders that have sold AdaptHealth company stock in the last year include Frank Mullen, Ronald T Mcdaniel, and Shaw Rietkerk.
View insider buying and selling activity for AdaptHealth
or view top insider-selling stocks.

Which institutional investors are buying AdaptHealth stock?

AHCO stock was bought by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, West Coast Financial LLC, and Russell Investments Group Ltd.. Company insiders that have bought AdaptHealth stock in the last two years include Alan G Quasha, Dale B Wolf, Jason A Clemens, and Stephen P Griggs.
View insider buying and selling activity for AdaptHealth
or or view top insider-buying stocks.

How do I buy shares of AdaptHealth?

Shares of AHCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $18.40.

How much money does AdaptHealth make?

AdaptHealth has a market capitalization of $2.43 billion and generates $1.06 billion in revenue each year. The company earns $-64.48 million in net income (profit) each year or ($0.23) on an earnings per share basis.

How many employees does AdaptHealth have?

AdaptHealth employs 4,700 workers across the globe.

What is AdaptHealth's official website?

The official website for AdaptHealth is www.adapthealth.com.

Where are AdaptHealth's headquarters?

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The company can be reached via phone at (610) 630-6357 or via email at [email protected].


This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.